![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CERNA2 |
Gene summary for CERNA2 |
![]() |
Gene information | Species | Human | Gene symbol | CERNA2 | Gene ID | 642934 |
Gene name | competing endogenous lncRNA 2 for microRNA let-7b | |
Gene Alias | HOST2 | |
Cytomap | 10q23.1 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
642934 | CERNA2 | AEH-subject1 | Human | Endometrium | AEH | 3.80e-37 | 6.77e-01 | -0.3059 |
642934 | CERNA2 | AEH-subject2 | Human | Endometrium | AEH | 4.61e-20 | 4.90e-01 | -0.2525 |
642934 | CERNA2 | AEH-subject3 | Human | Endometrium | AEH | 6.48e-14 | 3.41e-01 | -0.2576 |
642934 | CERNA2 | AEH-subject4 | Human | Endometrium | AEH | 1.10e-03 | 1.55e-01 | -0.2657 |
642934 | CERNA2 | AEH-subject5 | Human | Endometrium | AEH | 3.29e-02 | 9.73e-02 | -0.2953 |
642934 | CERNA2 | EEC-subject1 | Human | Endometrium | EEC | 2.24e-16 | 4.57e-01 | -0.2682 |
642934 | CERNA2 | EEC-subject2 | Human | Endometrium | EEC | 2.82e-42 | 7.60e-01 | -0.2607 |
642934 | CERNA2 | EEC-subject4 | Human | Endometrium | EEC | 4.20e-27 | 6.67e-01 | -0.2571 |
642934 | CERNA2 | EEC-subject5 | Human | Endometrium | EEC | 2.98e-34 | 7.63e-01 | -0.249 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Endometrium | ![]() | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Esophagus | ESCC | ![]() |
Skin | AK | ![]() |
Skin | SCCIS | ![]() |
Skin | cSCC | ![]() |
Thyroid | HT | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |